JP2005501039A - 可変放出割合を持つ薬剤制御放出システム - Google Patents

可変放出割合を持つ薬剤制御放出システム Download PDF

Info

Publication number
JP2005501039A
JP2005501039A JP2003513528A JP2003513528A JP2005501039A JP 2005501039 A JP2005501039 A JP 2005501039A JP 2003513528 A JP2003513528 A JP 2003513528A JP 2003513528 A JP2003513528 A JP 2003513528A JP 2005501039 A JP2005501039 A JP 2005501039A
Authority
JP
Japan
Prior art keywords
variable
drug controlled
controlled release
release rate
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003513528A
Other languages
English (en)
Other versions
JP2005519858A5 (ja
JP2005501039A6 (ja
Inventor
ジョン リチャード ラングリッジ
ジェニン クレア コリンズ
ウェイ ティアン
Original Assignee
フォークス ファーマシューティカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フォークス ファーマシューティカルズ リミテッド filed Critical フォークス ファーマシューティカルズ リミテッド
Publication of JP2005501039A publication Critical patent/JP2005501039A/ja
Publication of JP2005501039A6 publication Critical patent/JP2005501039A6/ja
Publication of JP2005519858A5 publication Critical patent/JP2005519858A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本文なし。

Description

本文なし。

Claims (1)

  1. 本文なし。
JP2003513528A 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム Pending JP2005501039A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117618.9A GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form
PCT/GB2002/003286 WO2003007919A1 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates

Publications (3)

Publication Number Publication Date
JP2005501039A true JP2005501039A (ja) 2005-01-13
JP2005501039A6 JP2005501039A6 (ja) 2005-02-24
JP2005519858A5 JP2005519858A5 (ja) 2009-10-22

Family

ID=9918808

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003513528A Pending JP2005501039A (ja) 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム
JP2003513528D Pending JP2005519858A (ja) 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003513528D Pending JP2005519858A (ja) 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム

Country Status (14)

Country Link
US (1) US20060099257A1 (ja)
EP (1) EP1406597A1 (ja)
JP (2) JP2005501039A (ja)
KR (1) KR20040032857A (ja)
CN (1) CN1556697A (ja)
AU (1) AU2002317360B2 (ja)
BR (1) BR0211156A (ja)
CA (1) CA2457308A1 (ja)
GB (1) GB0117618D0 (ja)
IL (1) IL159876A0 (ja)
MX (1) MXPA04000544A (ja)
RU (1) RU2004104950A (ja)
WO (1) WO2003007919A1 (ja)
ZA (1) ZA200401216B (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487417A4 (en) 2001-09-17 2010-03-17 Glaxo Group Ltd DRY POWDER DRUG FORMULATIONS
TW200517127A (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Novel composition
AR046410A1 (es) 2003-09-18 2005-12-07 Cephalon Inc Composiciones farmaceuticas para la liberacion modificada de modafinilo
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
KR20060115860A (ko) * 2003-09-26 2006-11-10 알자 코포레이션 활성 제제의 서방성 전달을 위한 ｏｒｏｓ 푸시-스틱
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
MXPA06003454A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada de analgesicos opioides y no opiodes.
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
KR101340946B1 (ko) * 2004-08-04 2013-12-13 알자 코포레이션 오름차 0차 방출 패턴을 나타내는 약물의 서방성 조성물,상기 조성물을 제조하는 방법
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8022032B2 (en) * 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
WO2007121188A2 (en) * 2006-04-10 2007-10-25 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
EP2497472A1 (en) 2006-05-16 2012-09-12 Knopp Neurosciences, Inc. Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and their pharmaceutical compositions
KR20090021169A (ko) * 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
ES2565629T3 (es) * 2006-05-23 2016-04-06 Orahealth Corporation Comprimido de adhesión oral bicapa con adhesivo de goma arábiga
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
WO2009122431A2 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd., Oral controlled release tablet
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
WO2010014952A2 (en) 2008-07-31 2010-02-04 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
AU2009281537A1 (en) * 2008-08-14 2011-06-30 Bioneer A/S Coated tablets with a remaining degradation surface over the time
JP2012500283A (ja) 2008-08-19 2012-01-05 ノップ ニューロサイエンシーズ、インク． （ｒ）−プラミペキソールを使用した組成物並びにその方法
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
CN102802418A (zh) * 2009-06-19 2012-11-28 诺普神经科学股份有限公司 用于治疗肌萎缩性侧索硬化的组合物和方法
PT2554168T (pt) 2010-03-29 2018-02-28 Astellas Pharma Inc Composição farmacêutica de libertação controlada
EP2481411A1 (en) * 2011-01-27 2012-08-01 Ratiopharm GmbH Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib
LT5850B (lt) 2011-08-31 2012-07-25 Česlovas Paplauskas Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams
US20130096479A1 (en) * 2011-10-18 2013-04-18 St. Teresa Medical, Inc. Method of forming hemostatic products
CA2859174C (en) 2011-12-12 2019-03-05 Orbis Biosciences, Inc. Sustained release particle formulations
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
HUE054185T2 (hu) 2013-07-12 2021-08-30 Knopp Biosciences Llc Eozinofilek és/vagy bazofilek megemelkedett szintjének kezelése
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
WO2015117004A1 (en) * 2014-01-31 2015-08-06 Board Of Regents, The University Of Texas System Method for preparing films
CN115645374B (zh) * 2022-12-25 2024-04-26 山东理工职业学院 一种硫酸沙丁胺醇片的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05500668A (ja) * 1989-09-22 1993-02-12 ブーク　メディテック　エイ／エス 制御放出組成物
JPH05508337A (ja) * 1991-02-22 1993-11-25 ヘキスト　ユーケイ　リミテッド 医薬錠剤コアにコーティング材料をコーティングする方法およびこの方法を実施するための装置
JPH09509412A (ja) * 1994-02-04 1997-09-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ２層アモキシシリン錠剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
KR19990008431A (ko) * 1995-05-09 1999-01-25 피터 존스 팔슨즈 정전 코팅
EP1269997A1 (en) * 1999-04-13 2003-01-02 Beecham Pharmaceuticals (Pte) Limited Unit dosage comprising amoxicillin and clavulanate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05500668A (ja) * 1989-09-22 1993-02-12 ブーク　メディテック　エイ／エス 制御放出組成物
JPH05508337A (ja) * 1991-02-22 1993-11-25 ヘキスト　ユーケイ　リミテッド 医薬錠剤コアにコーティング材料をコーティングする方法およびこの方法を実施するための装置
JPH09509412A (ja) * 1994-02-04 1997-09-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ２層アモキシシリン錠剤

Also Published As

Publication number Publication date
EP1406597A1 (en) 2004-04-14
ZA200401216B (en) 2005-03-17
CN1556697A (zh) 2004-12-22
US20060099257A1 (en) 2006-05-11
GB0117618D0 (en) 2001-09-12
BR0211156A (pt) 2004-08-10
AU2002317360B2 (en) 2006-08-17
JP2005519858A (ja) 2005-07-07
MXPA04000544A (es) 2005-06-06
RU2004104950A (ru) 2005-03-10
WO2003007919A1 (en) 2003-01-30
CA2457308A1 (en) 2003-01-30
IL159876A0 (en) 2004-06-20
KR20040032857A (ko) 2004-04-17

Similar Documents

Publication Publication Date Title
JP2005501039A (ja) 可変放出割合を持つ薬剤制御放出システム
JP2004525194A5 (ja)
JP2002532112A5 (ja)
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
DE60117859D1 (de) HARNSTOFFSUBSTITUIERTE IMIDAZOCHINOLINETHER und Arzneimittel, die diese umfassen.
NL1021321A1 (nl) Ophanginrichting.
JP2004518665A5 (ja)
ATE303386T1 (de) Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens
BR0116998B1 (pt) dispositivo osteossintético.
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
Vos Tuberculosis, adherence behaviour & the inner city
ES1048464Y (es) Mariposa de somier perfeccionada.
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами
Manning et al. The Human Kinome
Ruckeyser The Promise
ES1049573Y (es) Tarima de soporte perfeccionada.
NL1018038A1 (nl) De reuzenboomslinger.
ES1049419Y (es) Luminaria de emergencia perfeccionada.
ES1049731Y (es) Dispositivo para la administracion de farmacos.
BR8001273Y1 (pt) suspensório médico.
IT1320746B1 (it) Saliscendi per lampadario.
ES1048424Y (es) Colgador perfeccionado.
ES1049021Y (es) Ambientador de sobremesa multiforma.
ES1048432Y (es) Anzuelo perfeccionado.
ES1048644Y (es) Colgador de sobremesa perfeccionado.

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20041202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050527

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060425

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090601

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090608

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090701

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090710

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090728

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090804

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20090903

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20091002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091006

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100401

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100512

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20100730